Clinical Trials in Grabels, France
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Not Applicable
Hemodiafiltration Versus Hemodialysis in Older People
Older PeopleFatigue SymptomHemodialysis+2 more
AUB Santé62 enrolled4 locationsNCT07278973